Latest Arthritis News
"In addition to pain, profound fatigue reduces the quality of life for many people, even more than the swelling of the joints," EULAR's president, Iain McInnes, said in a league news release. He's a professor of rheumatology at the University of Glasgow in Scotland.
But doctors often don't pay enough attention to patients' fatigue, he added.
His two-year study included 80 RA patients who began a drug regimen immediately after their diagnosis. They received either 15 mg of methotrexate a week (control group) or a combination therapy. The combo included 15 mg of methotrexate and 30 mg of cortisone (prednisone) weekly, which was eventually reduced to 5 mg a week.
Patients who had intensive treatment with the drug combo for two years were less tired than those in the control group, even though both groups had similar disease activity over time, the study found.
Differences in fatigue levels between the two groups appeared to increase over time, according to the study.
"The early course of the disease could provide an opportunity to manage fatigue," De Cock said in the release.
The study was presented as an abstract online for EULAR's E-Congress 2020, which began earlier this month. Findings presented at meetings are typically viewed as preliminary until they've been published in a peer-reviewed journal.
Based on the findings, EULAR recommends early consideration of intensive treatment even in low-risk patients with RA.
RA affects about 1% people worldwide, according to EULAR.
-- Robert Preidt
Copyright © 2020 HealthDay. All rights reserved.